Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
โ
7.05%
Grew
โ
0.00%
Shrank
โ
1 Year
Scoreโ
Net Growth7.05%
Net TrendGrew
Net Income Consistencyโ
Rev Growth0.00%
Rev TrendShrank
Revenue Consistencyโ
All Time
โ
-107.71%
50%
โ
6x
50%
โ
All Time
Scoreโ
Net Growth-107.71%
Net Trend50%
Net Income Consistencyโ
Rev Growth6x
Rev Trend50%
Revenue Consistencyโ
See the full market ranking โ
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 98.36 | โ |
1 Year2025-08-12 | $ 21.92 | 348.72% |
All Time2024-05-29 | $ 11.66 | 8x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2024-05-29 |
|---|---|---|---|
| Price | $ 98.36 | $ 21.92 | $ 11.66 |
| Return | โ | 348.72% | 8x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 130M | $ 161M |
| 2025 | $ 1M | -$ 140M | $ 124M |
| IPO2024 | $ 200K | $ 1.68B | $ 152M |
Explore beyond INBX
You're looking at Inhibrx Biosciences, Inc.. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
